Related Experiment Video
Updated: Feb 9, 2026

Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
Donor-specific Antibody Surveillance and Graft Outcomes in Pediatric Kidney Transplant Recipients
Rachel M Engen1, Giulia E Park2, Cooper S Schumacher3
1Department of Pediatrics, University of Washington, Seattle, WA.
Insights
Screening for de novo donor-specific antibodies (dnDSA) in pediatric kidney transplant recipients did not predict graft loss. However, dnDSA detected during routine screening was linked to rejection, unlike dnDSA found due to symptoms.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- De novo donor-specific antibodies (dnDSA) are linked to kidney transplant rejection and graft loss.
- DSA screening is recommended for all kidney transplant recipients.
- The clinical significance of dnDSA detected during routine screening in stable patients is unclear.
Purpose of the Study:
- To investigate the clinical significance of dnDSA detected through screening versus for-cause testing in pediatric kidney transplant recipients.
- To determine the association between dnDSA and graft function, rejection, and graft loss.
Main Methods:
- One hundred three pediatric kidney transplant recipients underwent DSA screening every 3 months for 2 years post-transplant.
- dnDSA was monitored, with treatment only for biopsy-proven rejection.
- Follow-up averaged 4.4 years post-transplant.
Main Results:
- Twenty percent of patients developed dnDSA detected by screening; 13% developed dnDSA detected by for-cause testing.
- Screening-detected dnDSA correlated with increased rejection, microvascular inflammation, and C4d staining.
- Screening-detected dnDSA was not associated with reduced estimated glomerular filtration rate or graft loss.
- For-cause detected dnDSA significantly increased the risk of graft function decline and graft loss.
Conclusions:
- The clinical impact of dnDSA in kidney transplantation depends on how it is detected.
- dnDSA detected during routine screening in stable pediatric kidney transplant recipients did not predict graft loss.
- Further research is needed to define the role of dnDSA screening in pediatric kidney transplantation.
Background:
The development of de novo donor-specific antibodies (dnDSA) has been associated with rejection and graft loss in kidney transplantation, and DSA screening is now recommended in all kidney transplant recipients. However, the clinical significance of dnDSA detected by screening patients with a stable creatinine remains unclear.
Methods:
One hundred three patients younger than 18years receiving a first, kidney alone transplant between December 1, 2007, and December 31, 2013, underwent DSA screening every 3months for 2years posttransplant, with additional testing as clinically indicated. No treatment was given for DSAs in the absence of biopsy-proven rejection.
Results:
Twenty (19%) patients had dnDSA first detected on a screening test, and 13 (13%) patients had dnDSA first detected on a for-cause test. Mean follow-up time posttransplant was 4.4years. Screening-detected dnDSA was associated with an increased risk of rejection within 3years, microvascular inflammation, and C4d staining on a 2-year protocol biopsy. In a Cox proportional hazards regression, screening-detected dnDSA was not associated with time to 30% decline in estimated glomerular filtration rate (adjusted hazard ratio, 0.88; 95% confidence interval [CI], 0.30-2.00; P=0.598) or graft loss. dnDSA first detected on for-cause testing was associated with a 2.8 times increased risk of decline in graft function (95% CI, 1.08-7.27; P=0.034) and a 7.34 times increased risk of graft loss (95% CI, 1.37-39.23 P=0.020) compared with those who did not develop dnDSA.
Conclusions:
The clinical setting in which dnDSA is first detected impacts the association between dnDSA and graft function. Further research is needed to clarify the role of dnDSA screening in pediatric kidney transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Structure
Principles of Disease Surveillance
Predicting Reaction Outcomes

